Article Details

PDS Biotechnology: Advancement Of PDS0101 Continues With Expansion Data

Retrieved on: 2024-01-27 00:28:37

Tags for this article:

Click the tags to see associated articles and topics

PDS Biotechnology: Advancement Of PDS0101 Continues With Expansion Data. View article details on hiswai:

Excerpt

Preliminary efficacy results from phase 1/2 Mayo Clinic study, using PDS0101 + KEYTRUDA to treat patients with Oropharyngeal cancer, expected in Q2 ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo